172 related articles for article (PubMed ID: 33631352)
1. Identification of CYP2D6 Haplotypes that Interfere with Commonly Used Assays for Copy Number Variation Characterization.
Turner AJ; Aggarwal P; Boone EC; Haidar CE; Relling MV; Derezinski AD; Broeckel U; Gaedigk A
J Mol Diagn; 2021 May; 23(5):577-588. PubMed ID: 33631352
[TBL] [Abstract][Full Text] [Related]
2. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.
Gaedigk A; Fuhr U; Johnson C; Bérard LA; Bradford D; Leeder JS
Pharmacogenomics; 2010 Jan; 11(1):43-53. PubMed ID: 20017671
[TBL] [Abstract][Full Text] [Related]
3. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model.
Lee SB; Wheeler MM; Patterson K; McGee S; Dalton R; Woodahl EL; Gaedigk A; Thummel KE; Nickerson DA
Genet Med; 2019 Feb; 21(2):361-372. PubMed ID: 29875422
[TBL] [Abstract][Full Text] [Related]
4. Resolving discordant
Hongkaew Y; Wang WY; Gaedigk R; Sukasem C; Gaedigk A
Pharmacogenomics; 2021 Jun; 22(9):529-541. PubMed ID: 33998274
[No Abstract] [Full Text] [Related]
5. Prevalence of CYP2D6 structural variation in large retrospective study.
Frear S; Sherman A; Rule D; Marcath LA
Pharmacogenet Genomics; 2024 Jun; 34(4):135-138. PubMed ID: 38372405
[TBL] [Abstract][Full Text] [Related]
6. Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity.
Dalton R; Lee SB; Claw KG; Prasad B; Phillips BR; Shen DD; Wong LH; Fade M; McDonald MG; Dunham MJ; Fowler DM; Rettie AE; Schuetz E; Thornton TA; Nickerson DA; Gaedigk A; Thummel KE; Woodahl EL
Clin Transl Sci; 2020 Jan; 13(1):147-156. PubMed ID: 31536170
[TBL] [Abstract][Full Text] [Related]
7. Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.
Black JL; Walker DL; O'Kane DJ; Harmandayan M
Drug Metab Dispos; 2012 Jan; 40(1):111-9. PubMed ID: 22004686
[TBL] [Abstract][Full Text] [Related]
8. Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays.
Scantamburlo G; Tziolia K; Zopf M; Bernardinelli E; Soyal SM; Civello DA; Vanoni S; Dossena S; Patsch W; Patrinos GP; Paulmichl M; Nofziger C
Cell Physiol Biochem; 2017; 43(6):2297-2309. PubMed ID: 29073588
[TBL] [Abstract][Full Text] [Related]
9. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
Langaee T; Hamadeh I; Chapman AB; Gums JG; Johnson JA
PLoS One; 2015; 10(1):e0113808. PubMed ID: 25625348
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
11. Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population.
Fukunaga K; Hishinuma E; Hiratsuka M; Kato K; Okusaka T; Saito T; Ikeda M; Yoshida T; Zembutsu H; Iwata N; Mushiroda T
J Hum Genet; 2021 Feb; 66(2):139-149. PubMed ID: 32759992
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.
Gaedigk A; Twist GP; Leeder JS
Pharmacogenomics; 2012 Jan; 13(1):91-111. PubMed ID: 22111604
[TBL] [Abstract][Full Text] [Related]
13. CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping.
Riffel AK; Dehghani M; Hartshorne T; Floyd KC; Leeder JS; Rosenblatt KP; Gaedigk A
Front Pharmacol; 2015; 6():312. PubMed ID: 26793106
[TBL] [Abstract][Full Text] [Related]
14. Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
Numanagić I; Malikić S; Pratt VM; Skaar TC; Flockhart DA; Sahinalp SC
Bioinformatics; 2015 Jun; 31(12):i27-34. PubMed ID: 26072492
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.
Gaedigk A; Bhathena A; Ndjountché L; Pearce RE; Abdel-Rahman SM; Alander SW; Bradford LD; Rogan PK; Leeder JS
Pharmacogenomics J; 2005; 5(3):173-82. PubMed ID: 15768052
[TBL] [Abstract][Full Text] [Related]
16. Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
Buermans HP; Vossen RH; Anvar SY; Allard WG; Guchelaar HJ; White SJ; den Dunnen JT; Swen JJ; van der Straaten T
Hum Mutat; 2017 Mar; 38(3):310-316. PubMed ID: 28044414
[TBL] [Abstract][Full Text] [Related]
17. Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations.
Gaedigk A; Isidoro-García M; Pearce RE; Sánchez S; García-Solaesa V; Lorenzo-Romo C; Gonzalez-Tejera G; Corey S
Eur J Clin Pharmacol; 2010 Sep; 66(9):859-64. PubMed ID: 20473659
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants.
Gaedigk A; Jaime LK; Bertino JS; Bérard A; Pratt VM; Bradfordand LD; Leeder JS
Front Pharmacol; 2010; 1():121. PubMed ID: 21833166
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]